Cartesian Therapeutics (RNAC) Treasury Shares (2016 - 2025)
Historic Treasury Shares for Cartesian Therapeutics (RNAC) over the last 10 years, with Q3 2025 value amounting to $523254.0.
- Cartesian Therapeutics' Treasury Shares rose 1674.28% to $523254.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $523254.0, marking a year-over-year increase of 1674.28%. This contributed to the annual value of $444238.0 for FY2024, which is N/A changed from last year.
- Cartesian Therapeutics' Treasury Shares amounted to $523254.0 in Q3 2025, which was up 1674.28% from $533331.0 recorded in Q2 2025.
- In the past 5 years, Cartesian Therapeutics' Treasury Shares ranged from a high of $2.5 million in Q1 2023 and a low of $394450.0 during Q4 2021
- In the last 5 years, Cartesian Therapeutics' Treasury Shares had a median value of $567246.5 in 2021 and averaged $1.0 million.
- As far as peak fluctuations go, Cartesian Therapeutics' Treasury Shares skyrocketed by 47080.4% in 2021, and later crashed by 8115.69% in 2024.
- Cartesian Therapeutics' Treasury Shares (Quarter) stood at $394450.0 in 2021, then surged by 332.39% to $1.7 million in 2022, then grew by 20.37% to $2.1 million in 2023, then tumbled by 78.36% to $444238.0 in 2024, then grew by 17.79% to $523254.0 in 2025.
- Its last three reported values are $523254.0 in Q3 2025, $533331.0 for Q2 2025, and $572605.0 during Q1 2025.